WeVote
Log In

Bill

Bill

SB 150

Prohibiting the denial of coverage for the refilling of prescription topical eye medication.

2025-2026 Regular Session

Kansas bill prohibits insurers from denying coverage for prescription topical eye medication refills, ensuring timely patient access to essential vision-preserving treatments.

Died in Committee
#insurance
0
WeVote Research Nonpartisan
Bill Summary · SB 150

Legislative bill overview

SB 150 prohibits insurance companies and health plans from denying coverage for prescription refills of topical eye medications. The bill ensures that patients can obtain timely refills of eye drops and similar topical medications without facing coverage denials or prior authorization barriers that might delay treatment.

Why is this important

Eye conditions requiring topical medications—such as glaucoma, dry eye syndrome, and post-operative care—can deteriorate rapidly if treatment is interrupted. Denying refills can lead to vision loss, increased pain, or serious complications. This bill addresses a practical healthcare access issue that directly affects patient outcomes and emergency room visits.

Potential points of contention

  • Insurance industry costs: Insurers may argue this limits their ability to manage costs through utilization controls and could increase premium expenses, though eye medication costs are typically modest
  • Prior authorization necessity: Some insurers use prior authorization to prevent overuse or inappropriate prescribing; this bill may restrict their oversight tools without specifying safety guardrails
  • Scope ambiguity: The bill doesn't clarify whether it applies to all refills without limitation, potentially raising concerns about abuse (e.g., frequent early refills) versus legitimate patient access needs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.